1.Soluble CD93 as a Novel Biomarker in Asthma Exacerbation.
Naseh SIGARI ; Ali JALILI ; Laili MAHDAWI ; Ebrahim GHADERI ; Mohammadi SHILAN
Allergy, Asthma & Immunology Research 2016;8(5):461-465
Asthma research is shifting from studying symptoms and lung functions to the narrow-focus cellular profiles protein analysis, biomarkers, and genetic markers. The transmembrane glycoprotein CD93 is involved in endothelial cell migration, angiogenesis, leukocytes extravasation, apoptosis, innate immunity and inflammation. Relationships between the serum level of soluble CD93 (sCD93) and acute myocardial infarction/premature MI/inflammatory arthritis/skin sclerosis have recently been reported. We hypothesized that sCD93 would be elevated during the acute phase of asthma. We measured the serum level of sCD93 in 57 patients with asthma exacerbation and 57 age-and gender-matched healthy controls. Additionally, sCD93 was reassessed at the time of discharge from the hospital. Clinical characteristics and peak expiratory flow (PEF) of the patients were assessed. The primary outcome was the comparison of serum level of sCD93 between asthmatics and healthy subjects. The sCD93 values ranged from 128 to 789 ng/mL in asthmatics (345.83±115.81) and from 31 to 289 ng/mL in control subjects (169.46±62.43). The difference between the 2 groups was statistically significant (P<0.001). The association between sCD93 and asthma remained significant after adjusting for age, sex, and BMI. The differences between asthmatics and controls remained significant on the last day of hospital stay. The association between sCD93 and PEF was not significant. In conclusion, the serum level of soluble CD93 is increased in patients with asthma exacerbation. It also showed that serum levels of sCD93 decreased with treatment of asthma attack. The clinical usefulness of determination of sCD93 as a biomarker of asthma requires further studies.
Apoptosis
;
Asthma*
;
Biomarkers
;
Endothelial Cells
;
Genetic Markers
;
Glycoproteins
;
Healthy Volunteers
;
Humans
;
Immunity, Innate
;
Inflammation
;
Length of Stay
;
Leukocytes
;
Lung
;
Sclerosis
2.Comparison of the tuberculin skin test and the QuantiFERON-TB Gold test in detecting latent tuberculosis in health care workers in Iran.
Ehsan MOSTAFAVI ; Mahshid NASEHI ; Abdolrazagh HASHEMI SHAHRAKI ; Saber ESMAEILI ; Ebrahim GHADERI ; Saeed SHARAFI ; Amin DOOSTI-IRANI
Epidemiology and Health 2016;38(1):e2016032-
OBJECTIVES: The tuberculin skin test (TST) and the QuantiFERON-TB Gold test (QFT) are used to identify latent tuberculosis infections (LTBIs). The aim of this study was to determine the agreement between these two tests among health care workers in Iran. METHODS: This cross-sectional study included 177 tuberculosis (TB) laboratory staff and 67 non-TB staff. TST indurations of 10 mm or more were considered positive. The Student's t-test and the chi-square test were used to compare the mean score and proportion of variables between the TB laboratory staff and the non-TB laboratory staff. Kappa statistics were used to evaluate the agreement between these tests, and logistic regression was used to assess the risk factors associated with positive results for each test. RESULTS: The prevalence of LTBIs according to both the QFT and the TST was 17% (95% confidence interval [CI], 12% to 21%) and 16% (95% CI, 11% to 21%), respectively. The agreement between the QFT and the TST was 77.46%, with a kappa of 0.19 (95% CI, 0.04 to 0.34). CONCLUSIONS: Although the prevalence of LTBI based on the QFT and the TST was not significantly different, the kappa statistic was low between these two tests for the detection of LTBIs.
Cross-Sectional Studies
;
Delivery of Health Care*
;
Iran*
;
Latent Tuberculosis*
;
Logistic Models
;
Prevalence
;
Risk Factors
;
Skin Tests*
;
Skin*
;
Tuberculin*
;
Tuberculosis
3. Spatial distribution of cutaneous anthrax in western Iran from 2009 to 2016: Geographic information system mapping for predicting risk of anthrax outbreaks
Ebrahim GHADERI ; Behzad MOHSENPOUR ; Ghobad MORADI ; Mohammad KARIMI ; Fatemeh NAJAFI ; Seiran NILI ; Samaneh ROUHI
Asian Pacific Journal of Tropical Medicine 2020;13(5):227-234
To explore the spatial accumulation of diseases and their aggravating factors are essential in all public health. This study attempts to use geographic information system (GIS) to provide more information about the incidence and future of anthrax. Methods: Patients were diagnosed with anthrax in Kurdistan Province from 2009 to 2016. Data was then exported into ArcGIS software version 9 and the required layers for years and areas were added.Final map for each year was drawn up, pointing out the hot spots and predicting its future pattern. Results: Most cases were reported in females (57 cases, 54.80 %), and the lower body limbs were most affected (63 cases, 60.57%). The highest numbers of incidences were related to the cities of Marivan, Saqez and Divandareh, with more concentration in the central parts of the province, rather than borderline areas. The highest percentage of the probable incidence of the disease was in Sanandaj (57.74%) with a potential susceptible area of 1 729.12 km